aloxistatin and e 64
aloxistatin has been researched along with e 64 in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bogyo, M; Carruthers, VB; Teo, CF; Zhou, XW | 1 |
| Beaulieu, C; Ethier, D; Guay, D; Méthot, N; Percival, MD; Reddy, TJ; Riendeau, D; Rubin, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Barrett, AJ; Buttle, DJ; Saklatvala, J; Tamai, M | 1 |
| Hanada, K; Koyama, I; Matsumoto, K; Omura, S; Ozawa, Y; Tamai, M | 1 |
| Hosoya, J; Inazuki, K; Komatsu, K; Satoh, S | 1 |
| Alhassan, A; Govind, Y; Igarashi, I; Okubo, K; Yokoyama, N | 1 |
Other Studies
8 other study(ies) available for aloxistatin and e 64
| Article | Year |
|---|---|
Cysteine protease inhibitors block Toxoplasma gondii microneme secretion and cell invasion.
Topics: Animals; Cysteine Proteinase Inhibitors; Host-Parasite Interactions; Protozoan Proteins; Sulfones; Toxoplasma; Toxoplasmosis | 2007 |
Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing.
Topics: Animals; Cathepsin C; Cysteine Endopeptidases; Enzyme Inhibitors; Humans; Inflammation; Kinetics; Leukocyte Elastase; Models, Chemical; Myeloblastin; Neutrophils; Permeability; Rabbits; Serine Endopeptidases; U937 Cells | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by a lipophilic inactivator of cysteine endopeptidases.
Topics: Animals; Cartilage; Cattle; Cysteine Proteinase Inhibitors; Interleukin-1; Iodoacetates; Iodoacetic Acid; Leucine; Proteoglycans; Recombinant Proteins | 1992 |
In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64.
Topics: Animals; Calpain; Cathepsin B; Cathepsin L; Cathepsins; Cysteine Endopeptidases; Endopeptidases; Intestinal Absorption; Leucine; Male; Protease Inhibitors; Rats; Rats, Inbred Strains | 1986 |
Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice.
Topics: Animals; Body Weight; Creatine Kinase; Leucine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Muscular Dystrophy, Animal | 1986 |
Babesia bovis: effects of cysteine protease inhibitors on in vitro growth.
Topics: Animals; Babesia bovis; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Erythrocytes; Leucine; Leupeptins | 2007 |